LRP6 and colorectal cancer: In contrast, by inhibiting the expression of LRP6, miR-195 can downregulate the β-catenin signaling pathway and the transcription of target genes such as RUNX2 and VEGFa, which consequently reduces the metastasis of colorectal cancer [20].